NasdaqGM:ZLABBiotechs
Why Zai Lab (ZLAB) Is Down 9.6% After Leadership Shake-Up And Fast Track Win For Zoci
Earlier in May 2026, Zai Lab announced the departure of President and COO Josh Smiley as part of a leadership reshuffle to improve operational efficiency, while continuing preparations for key product launches and clinical milestones.
A few days earlier, the company had reported FDA Fast Track Designation for its investigational DLL3-targeting ADC zoci in extrapulmonary neuroendocrine carcinomas, highlighting progress in a cancer area with no established targeted options.
We’ll now examine...